Cellular Regulation of the Inflammatory Response
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
In simple terms, inflammation can be defined as a beneficial, nonspecific response of tissues to injury that generally leads to restoration of normal structure and function. In this concept, resolution of the inflammatory response, once it has achieved its protective and pro-immunogenic functions, becomes a critical determinant of what might be considered the paradox of inflammation. On one hand, inflammation is essential to resolve tissue injury and maintain homeostasis. On the other, inflammation is a key participant in the great majority of human diseases. Accordingly, to achieve complete resolution of inflammation, it is necessary to both turn off inflammatory mediator production and inflammatory cell accumulation and to remove inflammatory cells and debris without initiating an autoimmune response. Much of this process involves key activities of the mononuclear phagocyte series of cells, including resident and recruited macrophages. Recognition of activated and dying acute inflammatory cells by mononuclear phagocytes has been shown to (a) enhance macropinocytic activity for removal of debris, (b) enhance uptake of the effete inflammatory cells themselves, (c) induce inflammosuppressive and immunosuppressive mediators such as TGFβ and IL-10 that can down-regulate and limit proinflammatory mediator production, and (d) induce production of growth factors for tissue cells that may play key roles in tissue repair. Defects in these highly regulated processes are associated with persistent inflammation and/or autoimmunity in overaggressive resolution mechanisms such as nonresolving fibrosis or persistent tissue destruction as in emphysema.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · cited 2×
“…disease, or cancer, has led to a focus on the cytokines, chemokines, and other inflammatory mediators that orchestrate the process (Libby 2002; Nathan 2002; Tracey 2007; Hotamisligil 2006) to an extent that often downplays the critical role played by the cells that both induce and respond to…”
BackgroundResolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 1×
“Rather than providing a comprehensive review (for which, see Serhan and Savill 2005; Barton 2008; Han and Ulevitch 2005; Luster, Alon, and von Andrian 2005), we will alternatively raise a few general points and, more importantly, identify areas needing more intensive investigation.”
BackgroundPhysiology and immunology of the cholinergic antiinflammatory pathway
Tracey, K. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30555 · Cited by 1,563 · cited 2×
“Resurging interest in inflammation, for example as participating in obesity, cardiovascular disease, or cancer, has led to a focus on the cytokines, chemokines, and other inflammatory mediators that orchestrate the process (Libby 2002; Nathan 2002; Tracey 2007; Hotamisligil 2006) to an extent that often downplays the…”
BackgroundHomozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434 · cited 1×
“Similar findings have been reported in mice prone to autoimmunity (Scott et al. 2001; Hanayama et al. 2004; Kim et al. 2003; Ling, Pi, and Holoshitz 2007; Botto et al. 1998; Heidari et al. 2006).”
ResultImmune cell migration in inflammation: present and future therapeutic targets
Luster, A. D., Alon, R., & von Andrian, U. H. (2005) · Nature Immunology · doi:10.1038/ni1275 · Cited by 1,313
Phagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215 · cited 4×
“…of apoptotic neutrophils in vivo is highly efficient, to the degree that detection of dying neutrophils in injured tissues is normally difficult (Scott et al. 2001; Matute-Bello et al. 1997), even during the clearance phase of acute neutrophilic inflammation, as, for example, in bacterial…”
BackgroundResultInfluentialAutoimmune Disease and Impaired Uptake of Apoptotic Cells in MFG-E8-Deficient Mice
Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyama, Y., & Nagata, S. (2004) · Science · doi:10.1126/science.1094359 · Cited by 992 · cited 1×
“Similar findings have been reported in mice prone to autoimmunity (Scott et al. 2001; Hanayama et al. 2004; Kim et al. 2003; Ling, Pi, and Holoshitz 2007; Botto et al. 1998; Heidari et al. 2006).”
ResultA calculated response: control of inflammation by the innate immune system
Barton, G. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34431 · Cited by 532 · cited 1×
“Rather than providing a comprehensive review (for which, see Serhan and Savill 2005; Barton 2008; Han and Ulevitch 2005; Luster, Alon, and von Andrian 2005), we will alternatively raise a few general points and, more importantly, identify areas needing more intensive investigation.”
BackgroundHodge, S., Hodge, G., Scicchitano, R., Reynolds, P. N., & Holmes, M. (2003) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2003.t01-1-01170.x · Cited by 440 · cited 1×
“Such a defect in apoptotic cell removal has been shown (Hodge et al. 2003, 2006, 2005, 2007; Morimoto, Janssen, Fessler, McPhillips, et al. 2006; Morimoto, Janssen, Fesser, Xiao, et al. 2006; Richens et al. 2009).”
BackgroundClearance deficiency and systemic lupus erythematosus (SLE)
Gaipl, U. S., Munoz, L. E., Grossmayer, G., Lauber, K., Franz, S., Sarter, K., Voll, R. E., Winkler, T., Kuhn, A., Kalden, J., et al. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.02.005 · Cited by 277 · cited 1×
“…in apoptotic clearance mechanisms have been widely demonstrated in autoimmune diseases, such as systemic lupus erythematosus (Ren et al. 2003; Gaipl et al. 2005, 2007; Baumann et al. 2002; Herrmann et al. 1998) where increased numbers of apoptotic cells can be detected in the circulation…”
BackgroundDockrell, D. H., Marriott, H. M., Prince, L. R., Ridger, V. C., Ince, P. G., Hellewell, P. G., & Whyte, M. K. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5380 · Cited by 239 · cited 1×
“…is highly efficient, to the degree that detection of dying neutrophils in injured tissues is normally difficult (Scott et al. 2001; Matute-Bello et al. 1997), even during the clearance phase of acute neutrophilic inflammation, as, for example, in bacterial pneumonia (Dockrell et al. 2001, 2003).”
Background
Cited by
Redox control of inflammation in macrophages
Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., von Knethen, A., & Weigert, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4785 · Cited by 377
“Resolution of inflammation likely requires macrophage interaction with apoptotic resident cells (5, 128), leading to secretion of anti-inflammatory mediators such as TGFb or IL10 and modulation of ROS and NO production, as outlined in more detail below.”
BackgroundStem Cell Extracellular Vesicles: Extended Messages of Regeneration
Riazifar, M., Pone, E. J., Lötvall, J., & Zhao, W. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061616-030146 · Cited by 323
Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
Chu, E., Mychasiuk, R., Hibbs, M. L., & Semple, B. D. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02325-6 · Cited by 152
Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1
Fond, A. M., Lee, C. S., Schulman, I. G., Kiss, R. S., & Ravichandran, K. S. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80300 · Cited by 114
Metadata
- Authors
- Janssen, W. J., & Henson, P. M.
- Venue
- Toxicologic Pathology
- Publisher
- SAGE Publications
- Published
- 2011-11-16
- Volume
- 40
- Issue
- 2
- Pages
- 166-173
- ISSN
- 0192-6233 (ISSN-L)
- 1533-1601
- OpenAlex
- W2135146461
- Cited by
- 50
- References
- 12
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.